logo-loader
viewInnoCan Pharma

Israeli cannabis companies flower on the Canadian Securities Exchange

CEO Richard Carleton said the CSE is the go-to exchange for Israeli cannabis companies maximizing access to liquidity

stocks buds
Cannabis was the name of the game for the CSE in the last quarter, with cannabis and related issuers remaining the most active sector for capital raising

The Canadian Securities Exchange (CSE) is becoming increasingly popular with companies that are operating in Israel’s emerging cannabis sector.

In a statement, the CSE revealed Tuesday that three Israel-based cannabis companies including InnoCan Pharma Corp (CSE:INNO), Isracann Biosciences Inc (CSE:IPOT), and IM Cannabis Corp (CSE:IMCC) listed on the CSE over the past six weeks.

This represents the CSE's first listings from companies in Israel and is a result of a concerted push over the past two years to woo Israeli entrepreneurs eyeing a Canadian listing.

READ: CSE reports record-setting quarter; hits 500 issuers

"We are delighted to welcome these three companies," said Canadian Securities Exchange CEO Richard Carleton in a statement.

"Israeli cannabis firms typically have a deep portfolio of intellectual property and are building access to the emerging European cannabis market. Many of these companies have a strong need to access the public capital markets for growth funding. The CSE can play a key role in helping them achieve their objectives," he added.

The CSE’s rapidly growing stock exchange is focused on working with entrepreneurs to access the capital markets in Canada and internationally. It’s efficient operating model and low fee structure help companies minimize their costs and maximize access to liquidity.

"We have established the CSE as the 'go-to' exchange for companies in the Israeli cannabis industry," said Carleton.

"Our international outreach efforts are continuing, not just in Israel but also across Europe, Asia, South America and the Caribbean,” he added.

The CSE has seen a rapid increase in issuers, hitting 500 in the first quarter of 2019, a jump of 47.5% compared to the first quarter of 2018. Its issuers, which are active in diverse industries such as cannabis, technology and mining, have raised more than C$4.2 billion in the last 12 months

The exchange was founded in 2004 and has corporate offices in Toronto, Ontario and Vancouver, British Columbia.

Contact Uttara Choudhury at [email protected]

Follow her on Twitter: @UttaraProactive 

Quick facts: InnoCan Pharma

Price: 0.2 CAD

CSE:INNO
Market: CSE
Market Cap: $28.77 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of InnoCan Pharma named herein, including the promotion by the Company of InnoCan Pharma in any Content on the Site, the Company receives from...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

InnoCan Pharma looking at their CBD by injection technology as a game changer

InnoCan Pharma (CSE: INNO) CEO Iris Bincovich joined Steve Darling from Proactive in Toronto to talk about the CBDcompnay and some of their interesting technology including the development of CBD by Injection. Bincovich also told Proactive about their topical vertical that will focus on pain...

on 4/11/19

2 min read